Unicycive Therapeutics Stock (NASDAQ: UNCY) stock price, news, charts, stock research, profile.
Open | $1.080 |
Close | $1.130 |
Volume / Avg. | 280.362K / 412.003K |
Day Range | 1.050 - 1.140 |
52 Wk Range | 0.470 - 1.823 |
Market Cap | $40.991M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 43 |
Short Interest | 1.25% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Unicycive Therapeutics (NASDAQ: UNCY) through any online brokerage.
Other companies in Unicycive Therapeutics’s space includes: Fortress Biotech (NASDAQ:FBIO), Estrella Immunopharma (NASDAQ:ESLA), Gain Therapeutics (NASDAQ:GANX), OncoCyte (NASDAQ:OCX) and Immuneering (NASDAQ:IMRX).
The latest price target for Unicycive Therapeutics (NASDAQ: UNCY) was reported by Benchmark on Monday, April 15, 2024. The analyst firm set a price target for 3.00 expecting UNCY to rise to within 12 months (a possible 175.23% upside). 17 analyst firms have reported ratings in the last year.
The stock price for Unicycive Therapeutics (NASDAQ: UNCY) is $1.09 last updated May 10, 2024 at 7:40 PM EDT.
There are no upcoming dividends for Unicycive Therapeutics.
Unicycive Therapeutics’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Unicycive Therapeutics.
Unicycive Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.